Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology

Gerster, 1998, Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)?, Int. J. Vitam. Nutr. Res., 68, 159

Pawlosky, 2001, Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans, J. Lipid Res., 42, 1257, 10.1016/S0022-2275(20)31576-5

Burdge, 2005, Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults, Reprod. Nutr. Dev., 45, 581, 10.1051/rnd:2005047

Mayes, 2006, Variation in [U-13C] alpha linolenic acid absorption, beta-oxidation and conversion to docosahexaenoic acid in the preterm infant fed a DHA-enriched formula, Pediatr. Res., 59, 272, 10.1203/01.pdr.0000196372.29648.7a

Farquharson, 1992, Infant cerebral cortex phospholipid fatty-acid composition and diet, Lancet, 340, 810, 10.1016/0140-6736(92)92684-8

Farquharson, 1995, Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex, Arch. Dis. Child, 72, 198, 10.1136/adc.72.3.198

Su, 1999, Bioequivalence of dietary alpha-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons, Pediatr. Res., 45, 87, 10.1203/00006450-199901000-00015

Bowen, 2005, Maternal dietary 22:6n-3 is more effective than 18:3n-3 in increasing the 22:6n-3 content in phospholipids of glial cells from neonatal rat brain, Br. J. Nutr., 93, 601, 10.1079/BJN20041390

DeMar, 2005, alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid, J. Neurochem., 94, 1063, 10.1111/j.1471-4159.2005.03258.x

Neuringer, 1986, Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys, Proc. Natl. Acad. Sci. USA, 83, 4021, 10.1073/pnas.83.11.4021

Carrie, 2000, Specific phospholipid fatty acid composition of brain regions in mice. Effects of n-3 polyunsaturated fatty acid deficiency and phospholipid supplementation, J. Lipid Res., 41, 465, 10.1016/S0022-2275(20)34485-0

Byard, 1995, Sudden infant death syndrome: effect of breast and formula feeding on frontal cortex and brainstem lipid composition, J. Paediatr. Child Health, 31, 14, 10.1111/j.1440-1754.1995.tb02904.x

Xiao, 2005, Distribution, depletion and recovery of docosahexaenoic acid are region-specific in rat brain, Br. J. Nutr., 94, 544, 10.1079/BJN20051539

Diau, 2005, The influence of long chain polyunsaturated supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system, BMC Med., 3, 10.1186/1741-7015-3-11

Bourre, 1992, Structural and functional importance of dietary polyunsaturated fatty acids in the nervous system, Adv. Exp. Med. Biol., 318, 211, 10.1007/978-1-4615-3426-6_18

Breckenridge, 1973, Adult rat brain synaptic vesicles. II. Lipid composition, Biochim. Biophys. Acta, 320, 681, 10.1016/0304-4165(73)90148-7

Grandgirard, 1994, Incorporation of trans long-chain n-3 polyunsaturated fatty acids in rat brain structures and retina, Lipids, 29, 251, 10.1007/BF02536329

Yeh, 1993, Maternal dietary fish oil enriches docosahexaenoate levels in brain subcellular fractions of offspring, J. Neurosci. Res., 35, 218, 10.1002/jnr.490350213

Lee, 1991, Molecular species of diacylglycerols and phosphoglycerides and the postmortem changes in the molecular species of diacylglycerols in rat brains, J. Neurochem., 56, 370, 10.1111/j.1471-4159.1991.tb08161.x

Farooqui, 2004, Brain phospholipases A2: a perspective on the history, Prostaglandins Leukot. Essent. Fatty Acids, 71, 161, 10.1016/j.plefa.2004.03.004

Hong, 2003, Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation, J. Biol. Chem., 278, 14677, 10.1074/jbc.M300218200

Yavin, 2002, Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress, Nutr. Neurosci., 5, 149, 10.1080/10284150290003159

DeMar, 2004, Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids, J. Neurochem., 91, 1125, 10.1111/j.1471-4159.2004.02789.x

Rapoport, 2001, Delivery and turnover of plasma-derived essential PUFAs in mammalian brain, J. Lipid Res., 42, 678, 10.1016/S0022-2275(20)31629-1

Jumpsen, 1997, During neuronal and glial cell development diet n-6 to n-3 fatty acid ratio alters the fatty acid composition of phosphatidylinositol and phosphatidylserine, Biochim. Biophys. Acta, 1347, 40, 10.1016/S0005-2760(97)00046-5

Martinez, 1998, Fatty acid composition of human brain phospholipids during normal development, J. Neurochem., 71, 2528, 10.1046/j.1471-4159.1998.71062528.x

Ikemoto, 2000, Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus, Neurosci. Lett., 285, 99, 10.1016/S0304-3940(00)01035-1

Calderon, 2004, Docosahexaenoic acid promotes neurite growth in hippocampal neurons, J. Neurochem., 90, 979, 10.1111/j.1471-4159.2004.02520.x

Innis, 2001, Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain, J. Nutr., 131, 118, 10.1093/jn/131.1.118

Martin, 1998, Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells, J. Neurosci. Res., 54, 805, 10.1002/(SICI)1097-4547(19981215)54:6<805::AID-JNR8>3.0.CO;2-4

Martin, 1992, Changing fatty acid content of growth cone lipids prior to synaptogenesis, J. Neurochem., 59, 318, 10.1111/j.1471-4159.1992.tb08906.x

Bourre, 1992, Dietary alpha-linolenic acid deficiency in adult rats for 7 months does not alter brain docosahexaenoic acid content, in contrast to liver, heart and testes, Biochim. Biophys. Acta, 1124, 119, 10.1016/0005-2760(92)90087-C

Ahmad, 2002, Decrease in neuron size in docosahexaenoic acid-deficient brain, Pediatr. Neurol., 26, 210, 10.1016/S0887-8994(01)00383-6

Ahmad, 2002, A decrease in cell size accompanies a loss of docosahexaenoate in the rat hippocampus, Nutr. Neurosci., 5, 103, 10.1080/10284150290018973

Ahmad, 2004, Gray and white matter brain volume in aged rats raised on n-3 fatty acid deficient diets, Nutr. Neurosci., 7, 13, 10.1080/1028415042000202009

Sugiyama, 2002, Ultrastructural analysis of the paranodal junction of myelinated fibers in 31-month-old-rats, J. Neurosci. Res., 70, 309, 10.1002/jnr.10386

Yoshida, 1997, Synaptic vesicle ultrastructural changes in the rat hippocampus induced by a combination of alpha-linolenate deficiency and a learning task, J. Neurochem., 68, 1261, 10.1046/j.1471-4159.1997.68031261.x

Hamilton, 2000, n-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues, Lipids, 35, 863, 10.1007/S11745-000-0595-x

Murthy, 2002, Differential effects of n-3 fatty acid deficiency on phospholipid molecular species composition in the rat hippocampus, J. Lipid Res., 43, 611, 10.1016/S0022-2275(20)31491-7

Chalon, 1998, Dietary fish oil affects monoaminergic neurotransmission and behavior in rats, J. Nutr., 128, 2512, 10.1093/jn/128.12.2512

McLaughlin, 1995, The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions, Trends Biochem. Sci., 20, 272, 10.1016/S0968-0004(00)89042-8

Glaser, 1996, Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains, J. Biol. Chem., 271, 26187, 10.1074/jbc.271.42.26187

Rauch, 2002, Myristoylated alanine-rich C kinase substrate (MARCKS) sequesters spin-labeled phosphatidylinositol 4,5-bisphosphate in lipid bilayers, J. Biol. Chem., 277, 14068, 10.1074/jbc.M109572200

Wang, 2002, Lateral sequestration of phosphatidylinositol 4,5-bisphosphate by the basic effector domain of myristoylated alanine-rich C kinase substrate is due to nonspecific electrostatic interactions, J. Biol. Chem., 277, 34401, 10.1074/jbc.M203954200

Zhang, 2003, Binding of peptides with basic and aromatic residues to bilayer membranes: phenylalanine in the myristoylated alanine-rich C kinase substrate effector domain penetrates into the hydrophobic core of the bilayer, J. Biol. Chem., 278, 21459, 10.1074/jbc.M301652200

Bolsover, 2005, Calcium signalling in growth cone migration, Cell Calcium, 37, 395, 10.1016/j.ceca.2005.01.007

McNamara, 2004, The myristoylated alanine-rich C kinase substrate: a lithium-regulated protein linking cellular signaling and cytoskeletal plasticity, Clin. Neurosci. Res., 4, 155, 10.1016/j.cnr.2004.09.008

Kodas, 2004, Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat, J. Neurochem., 89, 695, 10.1111/j.1471-4159.2004.02401.x

Aid, 2003, Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus, J. Lipid Res., 44, 1545, 10.1194/jlr.M300079-JLR200

Zimmer, 2000, Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids, J. Lipid Res., 41, 32, 10.1016/S0022-2275(20)32071-X

Calabrese, 2005, Essential role for the PKC target MARCKS in maintaining dendritic spine morphology, Neuron, 48, 77, 10.1016/j.neuron.2005.08.027

Matus, 2000, Actin-based plasticity in dendritic spines, Science, 290, 754, 10.1126/science.290.5492.754

Zhou, 2004, How actin filaments and microtubules steer growth cones to their targets, J. Neurobiol., 58, 84, 10.1002/neu.10278

Newton, 2001, Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions, Chem. Rev., 101, 2353, 10.1021/cr0002801

Hundle, 1995, Overexpression of epsilon-protein kinase C enhances nerve growth factor-induced phosphorylation of mitogen-activated protein kinases and neurite outgrowth, J. Biol. Chem., 270, 30134, 10.1074/jbc.270.50.30134

Minami, 2000, Localization of mRNAs for novel, atypical as well as conventional protein kinase C (PKC) isoforms in the brain of developing and mature rats, J. Mol. Neurosci., 15, 121, 10.1385/JMN:15:2:121

Vaughan, 1998, The regulation of neurotransmitter secretion by protein kinase C, Mol. Neurobiol., 18, 125, 10.1007/BF02914269

de la Presa Owens, 1999, Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and α-linolenic acid deficient diet in formula-fed piglets, J. Nutr., 129, 2088, 10.1093/jn/129.11.2088

Delion, 1996, alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex, J. Neurochem., 66, 1582, 10.1046/j.1471-4159.1996.66041582.x

Bhattacharyya, 2002, Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms, Proc. Natl. Acad. Sci. USA, 99, 14470, 10.1073/pnas.212517999

Namkung, 2004, Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor, J. Biol. Chem., 279, 49533, 10.1074/jbc.M408319200

Loder, 2003, The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines, J. Biol. Chem., 278, 22168, 10.1074/jbc.M301845200

McNamara, 2006, Omega-3 fatty acid deficiency decreases dopamine D2 receptor binding and increases serotonin 5-HT2A receptor binding in the adult rat prefrontal cortex, Biol. Psychiatry, 59, S146

Moriguchi, 2000, Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration, J. Neurochem., 75, 2563, 10.1046/j.1471-4159.2000.0752563.x

Moriguchi, 2003, Recovery of brain docosahexaenoate leads to recovery of spatial task performance, J. Neurochem., 87, 297, 10.1046/j.1471-4159.2003.01966.x

Wainwright, 1998, Effects of dietary n-3 deficiency on Morris water-maze performance and amphetamine-induced conditioned place preference, Nut. Neurosci., 1, 281, 10.1080/1028415X.1998.11747238

Carrie, 2000, Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice, J. Lipid Res., 41, 473, 10.1016/S0022-2275(20)34486-2

DeMar, 2006, One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats, J. Lipid Res., 47, 172, 10.1194/jlr.M500362-JLR200

Nakashima, 1993, Effect of a high linoleate and a high alpha-linolenate diet on general behavior and drug sensitivity in mice, J. Lipid Res., 34, 239, 10.1016/S0022-2275(20)40751-5

McNamara, 2006, Omega-3 fatty acid deficiency increases dopamine concentrations in the nucleus accumbens and augments amphetamine-induced sensitization in sensitization-resistant inbred DBA/2J mice, Biol. Psychiatry, 59, S242

Anderson, 2005, Can prenatal N-3 fatty acid deficiency be completely reversed after birth? Effects on retinal and brain biochemistry and visual function in rhesus monkeys, Pediatr. Res., 58, 865, 10.1203/01.pdr.0000182188.31596.5a

Sarkadi-Nagy, 2003, The influence of prematurity and long chain polyunsaturate supplementation in 4-week adjusted age baboon neonate brain and related tissues, Pediatr. Res., 54, 244, 10.1203/01.PDR.0000072795.38990.F2

Neuringer, 1984, Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys, J. Clin. Invest., 73, 272, 10.1172/JCI111202

Reisbick, 1997, Visual attention in infant monkeys: effects of dietary fatty acids and age, Dev. Psychol., 33, 387, 10.1037/0012-1649.33.3.387

Diau, 2003, Docosahexaenoic and arachidonic acid influence on preterm baboon retinal composition and function, Invest. Ophthalmol. Vis. Sci., 44, 4559, 10.1167/iovs.03-0478

Giedd, 1999, Brain development during childhood and adolescence: a longitudinal MRI study, Nat. Neurosci., 2, 861, 10.1038/13158

Tisserand, 2002, Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry, Neuroimage, 17, 657, 10.1006/nimg.2002.1173

Carlson, 1986, Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula, Am. J. Clin. Nutr., 44, 798, 10.1093/ajcn/44.6.798

Carlson, 1999, Polyunsaturated fatty acid status and neurodevelopment: a summary and critical analysis of the literature, Lipids, 34, 171, 10.1007/s11745-999-0351-2

Gibson, 1996, Effect of dietary docosahexaenoic acid on brain composition and neural function in term infants, Lipids, 31, S177, 10.1007/BF02637072

Jamieson, 1999, Infant cerebellar gray and white matter fatty acids in relation to age and diet, Lipids, 34, 1065, 10.1007/s11745-999-0458-5

Nosarti, 2002, Adolescents who were born very preterm have decreased brain volumes, Brain, 125, 1616, 10.1093/brain/awf157

Peterson, 2000, Regional brain volume abnormalities and long-term cognitive outcome in preterm infants, J. Am. Med. Assoc., 284, 1939, 10.1001/jama.284.15.1939

Nagy, 2003, Preterm children have disturbances of white matter at 11 years of age as shown by diffusion tensor imaging, Pediatr. Res., 54, 672, 10.1203/01.PDR.0000084083.71422.16

Bhutta, 2002, Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis, J. Am. Med. Assoc., 288, 728, 10.1001/jama.288.6.728

Botting, 1997, Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years, J. Child Psychol. Psychiatry, 38, 931, 10.1111/j.1469-7610.1997.tb01612.x

Cherkes-Julkowski, 1998, Learning disability, attention-deficit disorder, and language impairment as outcomes of prematurity: a longitudinal descriptive study, J. Learn. Disabil., 31, 294, 10.1177/002221949803100309

Cooke, 2003, Growth impairment in the very preterm and cognitive and motor performance at 7 years, Arch. Dis. Child, 88, 482, 10.1136/adc.88.6.482

Foulder-Hughes, 2003, Motor, cognitive, and behavioural disorders in children born very preterm, Dev. Med. Child Neurol., 45, 97, 10.1111/j.1469-8749.2003.tb00912.x

Lawson, 2004, Early focused attention predicts outcome for children born prematurely, J. Dev. Behav. Pediatr., 25, 399, 10.1097/00004703-200412000-00003

Olsen, 1998, Psychological findings in preterm children related to neurologic status and magnetic resonance imaging, Pediatrics, 102, 329, 10.1542/peds.102.2.329

Carlson, 1996, A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months, Lipids, 31, 85, 10.1007/BF02522416

Helland, 2003, Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age, Pediatrics, 111, 39, 10.1542/peds.111.1.e39

Cheruku, 2002, Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning, Am. J. Clin. Nutr., 76, 608, 10.1093/ajcn/76.3.608

Colombo, 2004, Maternal DHA and the development of attention in infancy and toddlerhood, Child Dev., 75, 1254, 10.1111/j.1467-8624.2004.00737.x

P. Willatts, S. Forsyth, G. Mires, P. Ross, Maternal DHA status in late pregnancy is related to infant look duration and acuity at age 4 months. Poster presented at the meeting of the Society for Research in Child Development, Tampa, FL, 2003.

Innis, 2001, Are human milk long-chain polyunsaturated fatty acids related to visual and neural development in breast-fed term infants?, J. Pediatr., 139, 532, 10.1067/mpd.2001.118429

Daniels, 2004, Fish intake during pregnancy and early cognitive development of offspring, Epidemiology, 15, 394, 10.1097/01.ede.0000129514.46451.ce

Oken, 2005, Maternal fish consumption, hair mercury, and infant cognition in a US cohort, Env. Health Persp., 113, 1376, 10.1289/ehp.8041

Innis, 2004, Polyunsaturated fatty acids in human milk: an essential role in infant development, Adv. Exp. Med. Biol., 554, 27, 10.1007/978-1-4757-4242-8_5

Francois, 2003, Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk, Am. J. Clin. Nutr., 77, 226, 10.1093/ajcn/77.1.226

Sanders, 1979, A comparison of the influence of breast-feeding and bottle-feeding on the fatty acid composition of the erythrocytes, Br. J. Nutr., 41, 619, 10.1079/BJN19790077

Auestad, 1997, Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long chain polyunsaturated fatty acids for one year. Ross Pediatric Lipid Study, Pediatr. Res., 41, 1, 10.1203/00006450-199701000-00001

Uauy, 1992, Visual and brain function measurements in studies of n-3 fatty acid requirements of infants, J. Pediatr., 120, S168, 10.1016/S0022-3476(05)81252-1

Carlson, 1993, Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation, Am. J. Clin. Nutr., 58, 35, 10.1093/ajcn/58.1.35

Agostoni, 1995, Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids, Pediatr. Res., 38, 262, 10.1203/00006450-199508000-00021

Khedr, 2004, Neural maturation of breastfed and formula-fed infants, Acta Paediatr., 93, 734, 10.1111/j.1651-2227.2004.tb03011.x

Clandinin, 2005, Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid, J. Pediatr., 146, 461, 10.1016/j.jpeds.2004.11.030

Lauritzen, 2001, The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina, Prog. Lipid Res., 40, 1, 10.1016/S0163-7827(00)00017-5

van Wezel-Meijler, 2002, Dietary supplementation of long-chain polyunsaturated fatty acids in preterm infants: effects on cerebral maturation, Acta Paediatrica, 91, 942, 10.1111/j.1651-2227.2002.tb02882.x

Holman, 1998, The slow discovery of the importance of omega 3 essential fatty acids in human health, J. Nutr., 128, 427S, 10.1093/jn/128.2.427S

Biederman, 2006, Psychopathology in females with attention-deficit/hyperactivity disorder: a controlled, five-year prospective study, Biol. Psychiatry, 10.1016/j.biopsych.2006.02.031

Erlenmeyer-Kimling, 2000, Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project, Am. J. Psychiatry, 157, 1416, 10.1176/appi.ajp.157.9.1416

Keshavan, 2005, Premorbid indicators and risk for schizophrenia: a selective review and update, Schizophr. Res., 79, 45, 10.1016/j.schres.2005.07.004

Mitchell, 1983, Essential fatty acids and maladjusted behaviour in children, Prostagland. Leukot. Med., 12, 281, 10.1016/0262-1746(83)90006-9

Mitchell, 1987, Clinical characteristics and serum essential fatty acid levels in hyperactive children, Clin. Pediatr., 26, 406, 10.1177/000992288702600805

Richardson, 2002, A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties, Prog. Neuropsychopharm Biol. Psychiatry, 26, 233, 10.1016/S0278-5846(01)00254-8

Hirayama, 2004, Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder—a placebo-controlled double-blind study, Eur. J. Clin. Nutr., 58, 467, 10.1038/sj.ejcn.1601830

Brue, 2001, The use of a dietary supplement combination and an essential fatty acid as an alternative and complementary treatment for children with attention-deficit/hyperactivity disorder, Sci. Rev. Alt. Med., 5, 187

Harding, 2003, Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD, Alt. Med. Rev., 8, 319

Voigt, 2001, A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder, J. Pediatr., 139, 189, 10.1067/mpd.2001.116050

Joshi, 2006, Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD), Prostaglandins Leukot. Essent. Fatty Acids, 74, 17, 10.1016/j.plefa.2005.10.001

Ernst, 1998, DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study, J. Neurosci., 18, 5901, 10.1523/JNEUROSCI.18-15-05901.1998

Rosa Neto, 2002, Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit, Ann. NY Acad. Sci., 965, 434, 10.1111/j.1749-6632.2002.tb04184.x

Bymaster, 2002, Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder, Neuropsychopharmacology, 27, 699, 10.1016/S0893-133X(02)00346-9

Kalsbeek, 1988, Development of the dopaminergic innervation in the prefrontal cortex of the rat, J. Comp. Neurol., 269, 58, 10.1002/cne.902690105

Ilgin, 2001, Is increased D2 receptor availability associated with response to stimulant medication in ADHD, Dev. Med. Child Neurol., 43, 755, 10.1017/S0012162201001384

Verney, 1993, Immunocytochemical evidence of well-developed dopaminergic and noradrenergic innervations in the frontal cerebral cortex of human fetuses at midgestation, J. Comp. Neurol., 336, 331, 10.1002/cne.903360303

Zecevic, 1995, Development of the catecholamine neurons in human embryos and fetuses, with special emphasis on the innervation of the cerebral cortex, J. Comp. Neurol., 351, 509, 10.1002/cne.903510404

Castellanos, 2002, Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder, J. Am. Med. Assoc., 288, 1740, 10.1001/jama.288.14.1740

Sowell, 2003, Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder, Lancet, 362, 1699, 10.1016/S0140-6736(03)14842-8

Hill, 2003, Magnetic resonance imaging correlates of attention-deficit/hyperactivity disorder in children, Neuropsychology, 17, 496, 10.1037/0894-4105.17.3.496

Lyoo, 1996, The corpus callosum and lateral ventricles in children with attention-deficit hyperactivity disorder: a brain magnetic resonance imaging study, Biol. Psychiatry, 40, 1060, 10.1016/S0006-3223(96)00349-6

Christensen, 1988, Fat consumption and schizophrenia, Acta Psychiatr. Scand., 78, 587, 10.1111/j.1600-0447.1988.tb06388.x

Stokes, 2004, Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms, Nutr. Neurosci., 7, 247, 10.1080/10284150400010012

Evans, 2003, Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment, Prostaglandins Leukot. Essent. Fatty Acids, 69, 393, 10.1016/j.plefa.2003.08.010

Khan, 2002, Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics, Schizophr. Res., 58, 1, 10.1016/S0920-9964(01)00334-6

Reddy, 2004, Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline, Schizophr. Bull., 30, 901, 10.1093/oxfordjournals.schbul.a007140

McNamara, 2006, Reductions in the principle brain omega-3 fatty acid, docosahexaenoic acid, in postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder, but not multiple sclerosis or Alzheimer's disease, Biol. Psychiatry, 59, S30

McNamara, 2005, Fatty acid composition of the prefrontal and temporal cortex of schizophrenic, bipolar, and depressed patients, Biol. Psychiatry, 57, S192

Landen, 2002, Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia, Schizophr. Res., 55, 83, 10.1016/S0920-9964(01)00197-9

Yao, 2000, Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients, Schizophr. Res., 42, 7, 10.1016/S0920-9964(99)00095-X

Horrobin, 1991, Fatty acid levels in the brains of schizophrenics and normal controls, Biol. Psychiatry, 30, 795, 10.1016/0006-3223(91)90235-E

Arvindakshan, 2003, Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia, Schizophr. Res., 62, 195, 10.1016/S0920-9964(02)00284-0

Emsley, 2002, Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia, Am. J. Psychiatry, 159, 1596, 10.1176/appi.ajp.159.9.1596

Mellor, 1995, Schizophrenic symptoms and dietary intake of n-3 fatty acids, Schizophr. Res., 18, 85, 10.1016/0920-9964(95)00084-4

Peet, 2002, A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms, J. Psychiatr. Res., 36, 7, 10.1016/S0022-3956(01)00048-6

Dalman, 1999, Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort, Arch. Gen. Psychiatry, 56, 234, 10.1001/archpsyc.56.3.234

Ichiki, 2000, Intra-uterine physical growth in schizophrenia: evidence confirming excess of premature birth, Psychol. Med., 30, 597, 10.1017/S003329179900210X

Geddes, 1999, Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis, Schizophr. Bull., 25, 413, 10.1093/oxfordjournals.schbul.a033389

Jones, 1998, Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort, Am. J. Psychiatry, 155, 355, 10.1176/ajp.155.3.355

Davis, 1991, Dopamine in schizophrenia: a review and reconceptualization, Am. J. Psychiatry, 148, 1474, 10.1176/ajp.148.11.1474

Weinberger, 1987, Implications of normal brain development for the pathogenesis of schizophrenia, Arch. Gen. Psychiatry, 44, 660, 10.1001/archpsyc.1987.01800190080012

Gray, 2001, Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists, Brain Res. Bull., 56, 441, 10.1016/S0361-9230(01)00623-2

Amore, 2003, Can breast-feeding protect against schizophrenia? Case-control study, Biol. Neonate, 83, 97, 10.1159/000067960

McCreadie, 1997, The Nithsdale Schizophrenia Surveys. 16. Breast-feeding and schizophrenia: preliminary results and hypotheses,, Br. J. Psychiatry, 170, 334, 10.1192/bjp.170.4.334

Sorensen, 2005, Breastfeeding and risk of schizophrenia in the Copenhagen Perinatal Cohort, Acta Psychiatr. Scand., 112, 26, 10.1111/j.1600-0447.2005.00548.x

Leask, 2000, No association between breast-feeding and adult psychosis in two national birth cohorts, Br. J. Psychiatry, 177, 218, 10.1192/bjp.177.3.218

Sasaki, 2000, Type of feeding during infancy and later development of schizophrenia, Schizophr. Res., 42, 79, 10.1016/S0920-9964(99)00102-4

Keller, 2003, Corpus callosum development in childhood-onset schizophrenia, Schizophr. Res., 62, 105, 10.1016/S0920-9964(02)00354-7

Rapoport, 1999, Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study, Arch. Gen. Psychiatry, 56, 649, 10.1001/archpsyc.56.7.649

Sowell, 2000, Brain abnormalities observed in childhood-onset schizophrenia: a review of the structural magnetic resonance imaging literature, Ment. Retard. Dev. Disabil. Res. Rev., 6, 180, 10.1002/1098-2779(2000)6:3<180::AID-MRDD5>3.0.CO;2-I

Thompson, 2001, Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia, Proc. Natl. Acad. Sci. USA, 98, 11650, 10.1073/pnas.201243998

Bachmann, 2003, Corpus callosum in first-episode patients with schizophrenia—a magnetic resonance imaging study, Psychol. Med., 33, 1019, 10.1017/S0033291703008043

Bogerts, 1990, Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia, Psychiatry Res., 35, 1, 10.1016/0925-4927(90)90004-P

Flynn, 2003, Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins, Mol. Psychiatry, 8, 811, 10.1038/sj.mp.4001337

Gur, 1998, Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia, Am. J. Psychiatry, 155, 1711, 10.1176/ajp.155.12.1711

Gur, 2000, Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia, Arch. Gen. Psychiatry, 57, 761, 10.1001/archpsyc.57.8.761

Keshavan, 2002, Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia, J. Neurol. Neurosurg. Psychiatry, 72, 757, 10.1136/jnnp.72.6.757

Lim, 1996, Cortical gray matter volume deficit in patients with first-episode schizophrenia, Am. J. Psychiatry, 153, 1548, 10.1176/ajp.153.12.1548

Nopoulos, 1995, Brain morphology in first-episode schizophrenia, Am. J. Psychiatry, 152, 1721, 10.1176/ajp.152.12.1721

Szeszko, 2003, Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia, Am. J. Psychiatry, 160, 2190, 10.1176/appi.ajp.160.12.2190

Velakoulis, 1999, Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study, Arch. Gen. Psychiatry, 56, 133, 10.1001/archpsyc.56.2.133

Honea, 2005, Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies, Am. J. Psychiatry, 162, 2233, 10.1176/appi.ajp.162.12.2233

Arnold, 1995, Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions, Am. J. Psychiatry, 152, 738, 10.1176/ajp.152.5.738

Benes, 1991, Reduced neuronal size in posterior hippocampus of schizophrenic patients, Schizophr. Bull., 17, 597, 10.1093/schbul/17.4.597

Garey, 1998, Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia, J. Neurol. Neurosurg. Psychiatry, 65, 446, 10.1136/jnnp.65.4.446

Glantz, 2000, Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia, Arch. Gen. Psychiatry, 57, 65, 10.1001/archpsyc.57.1.65

Karson, 1999, Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for ‘hypofrontality’, Mol. Psychiatry, 4, 39, 10.1038/sj.mp.4000459

Rosoklija, 2000, Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings, Arch. Gen. Psychiatry, 57, 349, 10.1001/archpsyc.57.4.349

Baare, 2001, Volumes of brain structures in twins discordant for schizophrenia, Arch. Gen. Psychiatry, 58, 33, 10.1001/archpsyc.58.1.33

Cannon, 2002, Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia, Proc. Natl. Acad. Sci. USA, 99, 3228, 10.1073/pnas.052023499

McNeil, 2000, Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia, Am. J. Psychiatry, 157, 203, 10.1176/appi.ajp.157.2.203

Suddath, 1990, Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia, N. Engl. J. Med., 322, 789, 10.1056/NEJM199003223221201

Kunugi, 2003, Prenatal underdevelopment and schizophrenia: a case report of monozygotic twins, Psychiatry Clin. Neurosci., 57, 271, 10.1046/j.1440-1819.2003.01116.x

Hoving, 1994, Gestational age dependency of essential fatty acids in cord plasma cholesterol esters and triglycerides, Pediatr. Res., 35, 461, 10.1203/00006450-199404000-00015

Gilbert, 2003, Obstetric complications correlate with neurobehavioral and brain structural alterations in young relatives at risk for schizophrenia, Ann NY Acad. Sci., 1008, 269, 10.1196/annals.1301.030

Lawrie, 2001, Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia, Biol. Psychiatry, 49, 811, 10.1016/S0006-3223(00)01117-3

Cornblatt, 2002, The New York high risk project to the Hillside recognition and prevention (RAP) program, Am. J. Med. Genet., 114, 956, 10.1002/ajmg.b.10520

Oner, 2005, Attentional and neurocognitive characteristics of high-risk offspring of parents with schizophrenia compared with DSM-IV attention deficit hyperactivity disorder children, Schizophr. Res., 76, 293, 10.1016/j.schres.2005.01.005

Francois, 1998, Acute effects of dietary fatty acids on the fatty acids of human milk, Am. J. Clin. Nutr., 67, 301, 10.1093/ajcn/67.2.301

Lauritzen, 2002, Fluctuations in human milk long-chain PUFA levels in relation to dietary fish intake, Lipids, 37, 237, 10.1007/s11745-002-0886-2

Marangoni, 2002, Polyunsaturated fatty acids in maternal plasma and in breast milk, Prostaglandins Leukot. Essent. Fatty Acids, 66, 535, 10.1054/plef.2002.0396

Haggarty, 1999, Effect of maternal polyunsaturated fatty acid concentration on transport by the human placenta, Biol. Neonate, 75, 350, 10.1159/000014115

Haggarty, 2002, The effect of maternal smoking and ethanol on fatty acid transport by the human placenta, Br. J. Nutr., 87, 247, 10.1079/BJN2001514

Dutta-Roy, 2000, Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta, Am. J. Clin. Nutr., 71, S315, 10.1093/ajcn/71.1.315s

Jensen, 1995, Milk lipids. A. Human milk lipids, 495

Hibbeln, 2003, Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder, Biol. Psychiatry, 53, 431, 10.1016/S0006-3223(02)01549-4

de Leon, 1995, Schizophrenia and smoking: an epidemiological survey in a state hospital, Am. J. Psychiatry, 152, 453, 10.1176/ajp.152.3.453

Beijers, 1996, Long-chain polyunsaturated fatty acid content in Dutch preterm breast milk; differences in the concentrations of docosahexaenoic acid and arachidonic acid due to length of gestation, Early Hum. Dev., 44, 215, 10.1016/0378-3782(95)01710-0

Helland, 2001, Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women, Pediatrics, 108, E82, 10.1542/peds.108.5.e82

Olsen, 2002, Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study, Br. Med. J., 324, 447, 10.1136/bmj.324.7335.447

Smuts, 2003, A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy, Obstet. Gynecol., 101, 469, 10.1016/S0029-7844(02)02585-1

Bennedsen, 1999, Preterm birth and intra-uterine growth retardation among children of women with schizophrenia, Br. J. Psychiatry, 175, 239, 10.1192/bjp.175.3.239

Ichiki, 2000, Intra-uterine physical growth in schizophrenia: evidence confirming excess of premature birth, Psychol. Med., 30, 597, 10.1017/S003329179900210X

Olsen, 2000, Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team, BJOG, 107, 382, 10.1111/j.1471-0528.2000.tb13235.x

Dunstan, 2004, Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition, Eur. J. Clin. Nutr., 58, 429, 10.1038/sj.ejcn.1601825

Montgomery, 2003, Maternal docosahexaenoic acid supplementation and fetal accretion, Br. J. Nutr., 90, 135, 10.1079/BJN2003888

van Houwelingen, 1995, Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy, Br. J. Nutr., 74, 723, 10.1079/BJN19950175

Williams, 1995, Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia, Epidemiology, 6, 232, 10.1097/00001648-199505000-00007

Su, 2001, Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient, Eur. Neuropsychopharmacol., 11, 295, 10.1016/S0924-977X(01)00098-0

Kitessa, 2004, Supplementation of grazing dairy cows with rumen-protected tuna oil enriches milk fat with n-3 fatty acids without affecting milk production or sensory characteristics, Br. J. Nutr., 91, 271, 10.1079/BJN20031050

Raper, 1992, Omega-3 fatty acid content of the US food supply, J. Am. Coll. Nutr., 11, 304, 10.1080/07315724.1992.10718231

Simopoulos, 1999, Essential fatty acids in health and chronic disease, Am. J. Clin. Nutr., 70, S560, 10.1093/ajcn/70.3.560s

IOM Committee on Nutrient Relationships in Seafood: Selections to Balance Benefits and Risks, 2006, to be published.